Eculizumab as a fast-acting rescue therapy in a refractory myasthenic crisis: a case report

被引：21
作者：
Strano, Camilla M. M. [1 ,2 ]
Sorrenti, Benedetta [1 ,2 ]
Bosco, Luca [1 ,2 ]
Falzone, Yuri M. [1 ]
Fazio, Raffaella [1 ]
Filippi, Massimo [1 ,2 ,3 ,4 ,5 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Neurol Unit, Via Olgettina 60, I-20132 Milan, Italy
[2] Vita Salute San Raffaele & Univ, Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Inst Expt Neurol, Div Neurosci, Neuroimaging Res Unit, Milan, Italy
[4] Ist Sci San Raffaele, IRCCS Unit, Neurophysiol, Via Olgettina 60, I-20132 Milan, Italy
[5] Ist Sci San Raffaele, Neurorehabil Unit, Milan, Italy
来源：
JOURNAL OF NEUROLOGY | 2022年 / 269卷 / 11期
关键词：
D O I：
10.1007/s00415-022-11222-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：6152 / 6154
页数：3
相关论文
共 11 条
[1]   A systematic review of myasthenia gravis complicated with myocarditis [J].
Cheng, Wei ;
Sun, Tian ;
Liu, Cong ;
Zhou, Zijing ;
Duan, Jiaxi ;
Zhao, Yiyang ;
Yang, Min ;
Chen, Ping .
BRAIN AND BEHAVIOR, 2021, 11 (08)
[2]   Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder [J].
Frampton, James E. .
DRUGS, 2020, 80 (07) :719-727
[3]   Myasthenia Gravis [J].
Gilhus, Nils E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26) :2570-2581
[4]   The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria [J].
Hillmen, Peter ;
Young, Neal S. ;
Schubert, Joerg ;
Brodsky, Robert A. ;
Socie, Gerard ;
Muus, Petra ;
Roeth, Alexander ;
Szer, Jeffrey ;
Elebute, Modupe O. ;
Nakamura, Ryotaro ;
Browne, Paul ;
Risitano, Antonio M. ;
Hill, Anita ;
Schrezenmeier, Hubert ;
Fu, Chieh-Lin ;
Maciejewski, Jaroslaw ;
Rollins, Scott A. ;
Mojcik, Christopher F. ;
Rother, Russell P. ;
Luzzatto, Lucio .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12) :1233-1243
[5]   Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19 [J].
Hofstadt-van Oy, Ulrich ;
Stankovic, Slobodan ;
Kelbel, Corinna ;
Oswald, Daniel ;
Larrosa-Lombardi, Simon ;
Barchfeld, Thomas ;
Cleff, Ulrich .
JOURNAL OF NEUROLOGY, 2021, 268 (09) :3125-3128
[6]   Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis [J].
Oyama, Munenori ;
Okada, Kensuke ;
Masuda, Masayuki ;
Shimizu, Yuko ;
Yokoyama, Kazumasa ;
Uzawa, Akiyuki ;
Kawaguchi, Naoki ;
Ikeguchi, Ryotaro ;
Hoshino, Yasunobu ;
Hatano, Taku ;
Ozawa, Yukiko ;
Nakahara, Jin ;
Aizawa, Hitoshi ;
Kitagawa, Kazuo ;
Hattori, Nobutaka ;
Kuwabara, Satoshi ;
Murai, Hiroyuki ;
Suzuki, Shigeaki .
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
[7]   Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics [J].
Patriquin, Christopher J. ;
Kuo, Kevin H. M. .
TRANSFUSION MEDICINE REVIEWS, 2019, 33 (04) :256-265
[8]   The use of eculizumab in ventilator-dependent myasthenia gravis patients [J].
Usman, Uzma ;
Chrisman, Christina ;
Houston, Drew ;
Haws, Clara Chow ;
Wang, Alan ;
Muley, Suraj .
MUSCLE & NERVE, 2021, 64 (02) :212-215
[9]   Antibody Therapies in Autoimmune Neuromuscular Junction Disorders: Approach to Myasthenic Crisis and Chronic Management [J].
Vanoli, Fiammetta ;
Mantegazza, Renato .
NEUROTHERAPEUTICS, 2022, 19 (03) :897-910
[10]   Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab [J].
Wijnsma, Kioa Lente ;
ter Heine, Rob ;
Moes, Dirk Jan A. R. ;
Langemeijer, Saskia ;
Schols, Saskia E. M. ;
Volokhina, Elena. B. ;
van den Heuvel, Lambertus P. ;
Wetzels, Jack F. M. ;
van de Kar, Nicole C. A. J. ;
Bruggemann, Roger J. .
CLINICAL PHARMACOKINETICS, 2019, 58 (07) :859-874
12